TrialIntensive care medicine2022

Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial.

Jonathan A Silversides et al.PubMed ↗Publisher ↗

No numbers read from the abstract.